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 Note from the Editor 
This edition contains an important document 
from the IAP describing recommendations for 
reducing the risk of spreading paratuberculosis 
when trading livestock.  
 With less than six months to go before 
our next colloquium the IAP is calling for 
applications for awards to support travel for 
participants from lower income countries and to 
recognise outstanding graduate students as well 
as members who have contributed significantly 
to the Association – read on if you would like 
more information.  
 If you would like to post comments or 
discuss any of the articles in the newsletter with 
IAP members, just click on the ‘Post comments’ 
links provided.                                                                       
  Kumi de Silva 
 Cover photo: An ovine macrophage infected with GFP-MAP courtesy of Matt Johansen  
IAP business  
Guidelines for certification with respect to the movement of livestock for MAP 
infection
It is a pleasure for me to introduce the 
Guidelines for certification with respect 
to the movement of livestock for 
Mycobacterium avium subsp. 
paratuberculosis (MAP) infection. This is 
a document elaborated by a group of 
experts, IAP members and non-members 
that results from their voluntary work 
during many months since the first ideas 
started circulating in January 2016. 
 The authors have done a very good 
job taking into account different views and 
have come out with a highly consensual set 
of rules that no doubt will be of seminal 
value for control of such a difficult slow 
infectious disease as ruminant 
paratuberculosis. This document is just a 
scientific statement that does not pretend 
to take the place of national or international 
regulatory animal health authorities. On the 
contrary, it could be a starting point to help 
them to develop their task. 
 The document is also the first IAP 
approved document stating a standing on a 
specific control issue. For this, in the name 
of the International Association for 
Paratuberculosis, I want to congratulate 
and thank the authors and, in particular to 
David Kennedy for his leading role. 
Ramon A. Juste 
President of the IAP 
Post comments on the IAP website 
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1. Purpose 
To provide guidance for scientifically sound risk assessment of MAP infection that can be used 
by risk managers to reduce the risk of spread of MAP between populations of livestock, 
consistent with WTO standards for international trade.   
NOTE: These guidelines do not consider the risks of  
• MAP infecting people (EFSA 2017, Chiodini et al 2012, Waddell et al 2015, 
Waddell et al 2016), nor  
• Transmission via bovine semen (EFSA 2004).  
 
2. Introduction 
Despite increasing understanding of MAP and paratuberculosis (Johne’s disease), little progress 
has been made in limiting the spread of MAP between regions and countries. MAP has been 
detected in most countries where it has been investigated. Regrettably however, interest in MAP 
often only increases in countries and regions as they realise, too late, that they have endemic 
Johne’s disease (JD) or when another country wants to include MAP in health certification for 
animals or products. Knowledge gaps constraining successful control have been reviewed 
recently (Barkema et al, 2017). 
Article 3 of the World Trade Organization Agreement on the Application of Sanitary and Phytosanitary 
Measures (the SPS Agreement, World Trade Organisation, 2016) states that  
“To harmonize sanitary and phytosanitary measures on as wide a basis as possible, 
Members shall base their sanitary or phytosanitary measures on international standards, 
guidelines or recommendations, where they exist.” 
 
There has also been little progress in developing and applying scientifically sound movement 
requirements for MAP.  Since 2001, efforts through official channels such as OIE have not 
borne fruit and, for the past decade, the OIE Terrestrial Animal Health Code Chapter on 
Paratuberculosis has provided little guidance in this area (OIEa 2015).  Concern about the low 
accuracy of diagnostic tests in individual animals has been a major reason that the Code chapter 
has not been developed further. However, the OIE Diagnostic Manual (OIEb 2015) has been 
updated to also refer to diagnostic testing at herd level.  Herd level testing and other certification 
based on large scale surveillance has been implemented for other diseases for which negative 
individual animal tests provide limited assurance, such as bovine brucellosis, bovine tuberculosis 
and the prion diseases. 
The International Association for Paratuberculosis (IAP) agreed in 2015 to develop its own 
guidelines for importers and exporters who want to implement rational movement requirements, 
based on current understanding of managing MAP risks and consistent with the principles of the 
SPS Agreement. These recognise and recommend risk management that is justified and 
appropriate for different situations. 
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3. Rationale 
One of the Basic Obligations outlined in Article 2 of the SPS Agreement is that. 
“Members shall ensure that any sanitary or phytosanitary measure is applied only to the 
extent necessary to protect human, animal or plant life or health, is based on scientific 
principles and is not maintained without sufficient scientific evidence, except as provided 
for in paragraph 7 of Article 5.”  
which states that,  
“In cases where relevant scientific evidence is insufficient, a Member may provisionally 
adopt sanitary or phytosanitary measures on the basis of available pertinent information, 
including that from the relevant international organizations as well as from sanitary or 
phytosanitary measures applied by other Members. In such circumstances, Members shall 
seek to obtain the additional information necessary for a more objective assessment of 
risk and review the sanitary or phytosanitary measure accordingly within a reasonable 
period of time.” 
 
The IAP is a “relevant international organisation” under the SPS Agreement for 
paratuberculosis.  Founded in 1989, the IAP is a non-profit organization devoted to the 
advancement of knowledge and scientific achievement toward the eradication of 
paratuberculosis in domestic livestock and other species affected by MAP. It has approximately 
150 members from 30 countries, who are broadly representative of scientific and disease control 
expertise globally. 
 
Flawed Requirements 
 
Many official movement protocols have hindered, rather than enhanced, control of MAP 
infection as they are scientifically flawed and ineffective.  
Certification based on the recent herd or flock history of clinical disease and on testing of the 
individual animals to be moved is still common for a broad range of types of animals. However, 
the negative predictive value of such certification from endemically infected regions (ie the 
probability that a test negative animal is truly free from MAP) approaches zero.  
• Clinical disease is not a sensitive indicator of MAP infection and requiring a negative 
clinical history discourages farmers who want to trade from investigating or reporting 
suspect cases. 
• It encourages traders to move, or falsify the identity of, animals so as not to exclude 
farms with a positive history from trading opportunities. 
• Movement testing is often of consignments of young animals and sometimes with 
outdated tests.  
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Such protocols also have perverse effects by discouraging participation in herd classification 
programs and by penalising regions and herd owners actively trying to control MAP through 
surveillance, testing and vaccination.   
 
Unjustified Requirements 
 
The World Trade Organization Agreement on the Application of Sanitary and Phytosanitary 
Measures (the SPS Agreement, World Trade Organisation, 2016) opens,  
“Reaffirming that no Member should be prevented from adopting or enforcing measures 
necessary to protect human, animal or plant life or health, subject to the requirement that 
these measures are not applied in a manner which would constitute a means of arbitrary 
or unjustifiable discrimination between Members where the same conditions prevail or a 
disguised restriction on international trade”   
Furthermore, Article 2 paragraph 3 states that,  
“Members shall ensure that their sanitary and phytosanitary measures do not arbitrarily 
or unjustifiably discriminate between Members where identical or similar conditions 
prevail, including between their own territory and that of other Members.” 
And Article 5 paragraph 4 includes, 
“Members should, when determining the appropriate level of sanitary or phytosanitary 
protection, take into account the objective of minimizing negative trade effects.” 
Yet some countries, in which MAP is endemic, require certification when they themselves have 
no significant surveillance or control programs in place. And some markets require negative farm 
level assurance for young animals destined for slaughter in the short term.  
In contrast, the few regions that have vigorously controlled and stamped out MAP, may struggle 
for recognition and acceptance that they should set an allowable level of protection and require 
appropriate entry requirements based on risk analysis.   
 
4. MAP Risk Assessment 
Risk assessment and management programs (RAMPs) have become the keystone of modern on-
farm JD control programs. Many of the same principles can be applied at a regional level.  
Article 5 of the SPS Agreement defines risk assessment as  
1. “Members shall ensure that their sanitary or phytosanitary measures are based on an 
assessment, as appropriate to the circumstances, of the risks to human, animal or 
plant life or health, taking into account risk assessment techniques developed by the 
relevant international organizations. 
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2. “In the assessment of risks, Members shall take into account available scientific 
evidence; relevant processes and production methods; relevant inspection, sampling 
and testing methods; prevalence of specific diseases or pests; existence of pest- or 
disease-free areas; relevant ecological and environmental conditions; and quarantine 
or other treatment.” 
 
The epidemiology and pathogenesis of MAP infection is complex and varies between species.  
However, on balance, the scientific evidence indicates that the following key characteristics of 
MAP infection should be considered in assessing the risks of livestock being infected with MAP  
Herd or population level  
1. MAP is endemic in developed livestock industries worldwide and has been spreading 
around the world with the movement of livestock for over a century. 
2. Any country that has imported large numbers of livestock in recent decades from 
developed livestock industries is likely to have endemic MAP infection unless it has 
taken sound and vigorous action to reduce the risk of entry and/or to stamp it out. 
3. The likelihood that a country, region or herd/flock is not infected can only be 
demonstrated by ongoing negative herd or population testing and active surveillance 
on a large scale over long periods. 
4. A negative clinical history of MAP infection has a low negative predictive value of 
herd or flock status. 
Individual animal level 
1. Animals may become infected at any age but are most susceptible to becoming 
infected in the first few months of life. 
2. Infected animals may excrete some MAP organisms at any stage but excretion may 
be intermittent and the likelihood and rate and amount of excretion increases as the 
infection progresses with age.  
3. Diagnostic tests usually have low sensitivity until the later stages of infection and so a 
negative test of an individual animal has a low predictive value. 
4. Clinical signs of Johne’s disease occur late in infection and are not pathognomonic; 
the absence of clinical signs usually has a low predictive value in determining whether 
an animal is infected. 
5. The most important source of MAP is faeces, both in the clinical and pre-clinical 
stages. 
6. Infectious MAP organisms survive in the environment in large numbers for months 
with longer survival in areas protected from extreme heat, ultraviolet light and 
dessication (Jørgensen, 1977; Whittington et al 2004; Eppleston et al 2014).  
7. MAP strains that have adapted to one species can infect others, but little is known if 
the dynamics of interspecies transmission and the frequency of transmission may be 
greater if there is close contact between different species at the farm level (Verdugo 
et al 2014).  
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5. MAP Risk Management 
The results of risk assessments are not perfect, largely because of uncertainties in the input 
parameters and assumptions. Therefore, importing countries and regions that require 
certification for MAP should take responsibility for preventing MAP spreading in their own 
areas, both from local animals and from imported animals, should it be inadvertently introduced.  
The likelihood of MAP infection spreading from introduced animals and infecting populations 
into which they are introduced may be managed by: 
1. Preventing exposure of susceptible animals to infectious sources, especially feed, 
water and other materials contaminated by faeces. 
2. Removing from the population introduced and exposed animals that are suspected of 
being infected. 
3. Removing MAP from contaminated environments and disposing of contaminated 
materials. 
Although not permitted in all countries, increasing the immunity of susceptible animals by 
vaccination has also been successfully used to reduce the risk of spread of MAP in infected 
populations.  
 
6. Risk Classifications of Areas 
Free and low-prevalence areas are recognised under Article 6 of the SPS Agreement: 
2. “Members shall, in particular, recognize the concepts of pest- or disease-free areas and 
areas of low pest or disease prevalence. Determination of such areas shall be based on 
factors such as geography, ecosystems, epidemiological surveillance, and the effectiveness 
of sanitary or phytosanitary controls. 
3. Exporting Members claiming that areas within their territories are pest- or disease-free 
areas or areas of low pest or disease prevalence shall provide the necessary evidence 
thereof in order to objectively demonstrate to the importing Member that such areas are, 
and are likely to remain, pest-or disease-free areas or areas of low pest or disease 
prevalence, respectively. For this purpose, reasonable access shall be given, upon request, 
to the importing Member for inspection, testing and other relevant procedures.” 
 
For the purpose of these guidelines it is recommended that four concepts for area classifications 
be used: 
Free Area   
A country, zone or compartment in which MAP infection is notifiable and extensive and 
large-scale surveillance for MAP infection by the animal health authority has not 
identified endemic infection for ten years or where infection has been introduced it has 
been demonstrably stamped out by slaughter and intensive tracing of suspect infection 
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and intensive surveillance has not identified MAP for 2 years. A Free Area will retain its 
status as long as appropriate area biosecurity and surveillance are maintained. 
Eradication Area 
A country, zone or compartment in which MAP infection is at low prevalence, is 
notifiable and extensive and large-scale compulsory surveillance for MAP infection by 
the animal health authority continues to demonstrate a low herd prevalence of infection 
and where the herd prevalence of infection is demonstrably being reduced as infection is 
stamped out.  
Officially sanctioned and recognised voluntary or compulsory herd or flock classification 
programs, with a certification component based on negative herd and/or flock testing 
and surveillance, may also operate to objectively classify herds and/or flocks for MAP 
risk. 
Certification Area 
A country, zone or compartment in which an officially sanctioned and recognised 
voluntary herd or flock classification programs, with a certification component based on 
sound farm biosecurity and negative herd and/or flock testing and surveillance operates 
to objectively classify herds and/or flocks for MAP risk. A certification area may not 
necessarily be a low prevalence area. 
Other Area   
All other countries and regions. 
 
7. Herd or Flock Classification 
In Free Areas, herds and flock status is derived from the area status.  
A herd or flock classification program in areas other than Free Areas should satisfy the following 
criteria: 
a. Sanctioned and recognised by the official animal health authority of the Area. 
b. Herds and flocks are under the supervision of a veterinarian who has been trained and 
approved for the purpose of the program. 
c. An officially recognised register of classified herds and flocks.  
d. Within each herd or flock the program will include: 
- permanent individual animal identification. 
- traceability of animals entering and leaving. 
- a farm-level biosecurity and management component to minimise the probability 
of MAP entering and spreading. 
- screening of adult animals by a sensitive and specific diagnostic test that is 
recommended by the IAP and approved by the regulator for the purpose. 
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- a test-strategy that appropriately documents a specific probability of freedom 
from infection  
 
For the purposes of these guidelines a single herd or flock classification is proposed in areas 
other than Free Areas, MAP Certified, which satisfies the importing Area’s appropriate level of 
protection and is defined as follows: 
a. Located within an Eradication Area or a Certification Area which is under the control of 
the animal health authority which also sanctions and recognises the herd or flock 
classification program for MAP, and 
b. Taking into consideration its location, history and management, the herd or flock has  
i. implemented biosecurity measures to minimise the likelihood of introduction 
and/or spread of MAP, and 
ii. repeatedly screened a representative sample of adult animals from the herd or 
flock (or the whole adult herd/flock) using IAP recommended tests and 
appropriate sample sizes to provide a specified level of confidence of detecting a 
specified low prevalence of infection (if present). See Martin et al (1992) and 
MacDiarmid (1988) and More et al (2013) for more information. 
 
Individual programs may use other and/or additional classifications to denote various risk 
statuses. 
 
8. Recommended tests 
Numerous tests have been developed for detection of statuses related to MAP, but few have 
been evaluated using state-of-the-art diagnostic test evaluations. (See Table 1 Test methods 
available for diagnosis of paratuberculosis and their purpose in the OIE Terrestrial Manual 
Chapter 2.1.11 adopted 2014). 
Testing for only one target condition is currently relevant to trade of livestock:  
• MAP infected animal, which is any animal carrying MAP intracellularly 
To detect MAP infection, the indirect antibody ELISA (for serum or milk), faecal PCR and 
faecal bacteriological culture are appropriate.  
Detection of a MAP exposed animal  (ie any animal that has been known or suspected to have 
been exposed to MAP infected animals in their lifetime, directly or indirectly via the 
environment), could also be relevant, but at present no tests have been satisfactorily evaluated.  
If “MAP exposure” is included as a target condition for certification, PCR and faecal culture may 
be considered 100% specific. 
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For the combined target condition, ie MAP exposure or MAP infection, the sensitivity of PCR is 
likely to be the highest, followed by culture and ELISA. However, the specific test that is used 
should be evaluated for the specific purpose prior to use in a certification programme. 
Experience with tests such as faecal smears, complement fixation test (CFT) and agar gel 
immunodiffusion test (AGID) indicate that they have inherently low sensitivity and/or 
specificity and are therefore not recommended. 
 
9. Test strategies 
In developing test strategies to suit the local livestock production systems a number of factors 
should be taken into account.  Most importantly, testing of individuals does not provide 
sufficient information to certify the individual or the herd/flock. The certification is affected by 
animal and herd/flock factors, and may be further affected by other local factors. For example: 
• The probability of an animal being free of MAP infection can be calculated if multiple 
animals from the same herd or flock have been tested (Sergeant et al., 2008; More et al., 
2013). However repeated sampling is required to achieve a high level of confidence that the 
herd or flock is free from MAP.  
• Current knowledge (ie prior information) about the prevalence of MAP in the region and in 
the herd or flock of origin and the probability of introduction of MAP into the herd or flock 
are important.  The higher the probability of existing infection, or of past introduction of 
infection, the higher the number of samplings and the longer the period of time that will be 
required to attain a high level of confidence of freedom. 
• Diagnostic sensitivity does not only depend on the test used, but also on the strain of MAP 
and age structure of target population.  
• Test antigens could be derived from local strains of MAP where required, but for 
standardisation of interpretation in an international context this should be minimised. 
• Average test sensitivity will be lower in a young population, because many infections will not 
have progressed to detectable stages. On the other hand, an old population may have many 
animals that are more likely to have remained in the herd or flock because they were un-
infected (This is recognised as “healthy worker survivor bias” and should be avoided). 
Therefore, the highest sensitivity can likely be achieved by testing the age-groups where 
infected animals would normally be expected to have started excreting detectable amounts of 
bacteria or to have sero-converted. It is usually recommended to test animals between 2 and 
5 years of age. However, consideration should be given to the species, management systems 
and the pressure of infection in the herd or flock. For instance, in systems with high stocking 
densities and high faecal contamination, the pressure of infection is likely to be higher and 
infection is likely to progress more quickly.    
Specifically, we recommend that  
• As many animals (above 2 years of age) as possible are tested with standardised and 
evaluated ELISAs, PCRs or culture methods. 
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• Test-evaluations should be carried out locally and age-stratified, if possible.  
• Test-prevalences (ie apparent prevalences) should be converted to true (calculated) 
prevalences, including 95% confidence intervals, and probabilities of freedom, and historical 
data should be included in the process, such as described in Sergeant et al. (2008) and More 
et al. (2013).  Where random sampling has been used, these calculations take into account the 
test-accuracy and the size and age-structure of the tested population. 
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Table 1. MAP statuses of importing and exporting areas and the 
recommended standards for various animal movements 
  
Livestock 
The following levels of protection and certification requirements are recommended for areas of 
various MAP status (Column 1) importing various types of livestock (Column 3) from Areas of 
different MAP status (Column 2). 
 
MAP status of 
Importing 
Area 
MAP status of 
Exporting Area 
Type of animal Acceptable Level of 
Protection/ MAP 
Certification 
Free Area Free Area All Throughout their lifetimes the 
animals have only resided in a 
Free Area or have satisfied the 
requirements to be be 
introduced to the Free Area.  
Eradication Area Animals for breeding  
Other restocking 
(including feeding for 
slaughter, but not in 
quarantine).  
 
Throughout their lifetimes the 
animals have only resided in a 
MAP Certified herd or flock. 
 
 Animals for confined 
feeding for slaughter, 
in quarantine. 
Animals for immediate 
slaughter 
No requirements. (The 
importing regulator will enact 
quarantine procedures that are 
sufficient to manage the risk) 
Certification 
Area 
Animals for breeding  
Other restocking 
(including feeding for 
slaughter but not in 
quarantine).  
Throughout their lifetimes the 
animals have only resided in a 
MAP Certified herd or flock  
 
Animals for confined 
feeding for slaughter, 
No requirements. (The 
importing regulator will enact 
quarantine procedures that are 
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in quarantine. 
Animals for immediate 
slaughter 
sufficient to manage the risk) 
Other Areas Animals for breeding  
Other restocking 
(including unconfined 
feeding for slaughter). 
Not permitted 
Animals for confined 
feeding for slaughter, 
in quarantine. 
Animals for immediate 
slaughter 
No requirements (The 
importing regulator will enact 
quarantine procedures that are 
sufficient to manage the risk) 
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Eradication 
Area 
Free Area All Throughout their lifetimes the 
animals have only resided in a 
Free Area or have satisfied the 
requirements to be been 
introduced to the Free Area.  
Eradication Area Animals for breeding  
Other restocking 
(including unconfined 
feeding for slaughter). 
Throughout their lifetimes the 
animals have only resided in a 
MAP Certified herd or flock. 
Animals for confined 
feeding for slaughter 
Animals for immediate 
slaughter 
No requirements (The 
importing regulator will enact 
quarantine procedures that are 
sufficient to manage the risk) 
Certification 
Area 
Animals for breeding  
Other restocking 
(including unconfined 
feeding for slaughter).  
No requirements. (The 
importing owner will manage 
the risk.) 
 
Animals for confined 
feeding for slaughter 
Animals for immediate 
slaughter 
. 
Other Areas Animals for breeding  
Other restocking 
(including unconfined 
feeding for slaughter). 
Not permitted 
Animals for confined 
feeding for slaughter 
Animals for immediate 
slaughter 
No requirements 
Certification 
Area 
All Areas All No requirements. (The 
importing owner will manage 
the risk.) 
Other Area All Areas All No requirements 
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Embryos. 
Embryos that have been sourced from donors that were clinically healthy at the time of 
collection and have been treated, handled and stored according to the procedures of the 
International Embryo Transfer Society may be imported into any Area. The IETS classifies MAP 
as an organism for which, in cattle, “preliminary evidence indicates that the risk of transmission 
is negligible provided that the embryos are properly handled between collection and transfer 
according to the IETS Manual” (IETS). 
 
Manure.  
Faeces is the most important carrier of MAP.  The identification and traceability of manure is 
problematic and therefore all manure should be assessed as high risk unless it is derived from a 
Free Area.   Managing the risk presented by manure is also difficult as large numbers of MAP 
organisms may survive in soil and water and be dispersed in the environment (see Grant, 2010).  
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 Call  for member support and recognition awards for the 14th ICP
 
Awards: 
- Emeritus 
- Richard Merkal Memorial Fellowship 
- Helping Hand
 
 
 
 
IAP Member Support and Recognition 
Committee 
Chairman:  Ramon A. Juste 
Members: Lucy Mutharia 
  Douwe Bakker 
  Douglas Begg 
  Nicola Pozzato 
Emeritus Awards 
The status of Emeritus member of the IAP has the goal of acknowledging the merits of long 
standing members that have retired and that have made significant contributions to the goals 
of the Association. In order to continue fulfilling this objective for the 14 ICP, the IAP launches 
a call for nominations according to the following guidelines. 
 
Award contents: 
Up to 3 awards will be granted based on the number and quality of nominees and the available 
funds. 
Each award will include:  
 1) free full registration for the 14 ICP and following editions 
 2) free lifelong IAP membership  
 3) Up to US$1500.00 reimbursement for travel expenses (payable on arrival at the 14 
ICP) 
 4) a certificate 
 5) a plate or plaque 
 
Nominations must be written by an IAP member in good standing and should contain 
information on the nominees including the following points to be evaluated in order of 
decreasing importance: 
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Scientific merits Qual ative (importance of knowledge generated on Map-relat d 
issues) 
Quantitative (number of papers produced, years working on 
paratuberculosis) 
Responsibilities Na onal (positions held, advisory committees, researcher 
training, services provided, meetings organized, etc.) 
International (positions held, advisory c mmittees, researcher 
training, services provided, meetings organized, etc.) 
IAP involvement National representation, offices held, colloquia organization, 
newsletter contributions, etc. 
Other Other merits not specified above 
 
Nominations should be ent by e-mail to the Secretary-Treasurer of the IAP 
(rsweeney@vet.upenn.edu), a d must include a letter containing all the information necessary 
for evaluation of the nominee as stated above. This document shall be an attache  Word or 
Adobe pdf file blocked for changes.  The IAP Member Support and Recognition Committee will 
evaluate the applications in the name of the IAP and its decisions are final. 
 
Timetable: 
Deadline for nominations:  Ja uary 15, 2018 
Announcement of awards: February 15, 2018 
 
Richard Merkal Memorial Fellowship 
The Association will provide funding for the participation of two graduate students to attend 
each Colloquium of the Association. Selection will be based on potential for future contributions 
to the field and scientific merit of a submitted abstract. Funding will include ir fare, lodging, 
general registration and a per diem for meals. All applicants must be members of the 
Association or sponsored by a member of the Association. The fellowships will not be open to 
applicants having residence in the same country in which the C lloquium is being held.  
 
 
Award contents: 
Up to Two Fellowships will be granted. 
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Each fellowship will include: 
 1) free full registration for the 14 ICP 
 2) Reimbursement for travel and lodging expenses, and a per diem for meals. 
(Maximum reimbursement not to exceed US$3000.) 
 3) a certificate 
 4) a plate 
 
Timetable: 
Deadline for applications:  Janu ry 15, 2018 
Announcement of awards: February 15, 2018 
 
Application for Richard MerkalFellowship to attend the 14th International 
Colloquium on Paratuberculosis (14ICP) in Riviera Maya, Mexico, June 4-8 June, 
2018 
Name:  
Date of Birth:  
Educational Qualifications: 
Current affiliation: 
      Institution: 
      Country: 
      Group leader: 
Publications in Paratuberculosis Research: 
Abstract of intended presentation: 
STATEMENT OF PURPOSE AND IMPORTANCE OF RESULTS TO BE PRESENTED  
 
Applications should be sent by e-mail addressed to the Secretary-Treasurer of the IAP 
(rsweeney@vet.upenn.edu), a d must include the completed forms provided in the call for 
applications as an attached Word or Adobe pdf file blocked for changes. The IAP Member 
Support and Recognition Committee will evaluate the applications in the name of the IAP and 
its decisions are final. 
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Helping Hand Fellowships 
The Association, b sed on the availability of funds and as determined by the Governing Board, 
will provide funding for up to 5 individuals from lower income countries to participate in each 
Colloquium of The Association. Selection of these individuals will be based on the economic 
status of the individual’s country of origin, a written statement of interest in paratuberculosis, 
potential for future contributions to the field, and scientific merit of a submitted abstract if one 
has been submitted (abstract submission is not required). 
 
Program specifications: 
Up to 5 awards will be granted based on the number and quality of applicants and the available 
funds. 
Each award will include:  
 1) free full registration for the 14 ICP  
 2) free IAP membership for 2018 and 2019  
 3) US$1000 stipend for travel expenses (payable in cash on arrival at the 14 ICP) 
 4) a certificate 
 
Timetable: 
Deadline for applications:  Janu ry 15, 2018 
Announcement of awards: February 15, 2018 
 
Criteria (listed in order of decreasing importance): 
1.- Country of origin:  Strong preference will given to applicants currently residing in countries 
not considered “high income” based on the website of the World Bank 
(https://openknwledge.worldbank.org/handle/10986/23628). Applicants originally from 
countries not considered “high income” but currently residing in “high income” countries will be 
considered only in the case that there were not enough candidates from the first category. 
2.- Statement of purpose:  The applicant must provide a written statement (in English) 
explaining their interest and experience in paratuberculosis, what they know of the 
paratuberculosis situation in their country, and why they would like to attend the 14 ICP. 
3.- 14 ICP abstract:  An abstract for a presentation at the 14 ICP concerning any aspect of 
paratuberculosis is mandatory for applicants from countries that have already received two or 
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more HH awards during the last 5 year period. For applicants from other c untries, an abstract 
would be positively considered but is not mandatory. 
4.- Applicant status: Applicants may or not be members of the IAP. If they are not, they must 
be nominated by a member in good standing for the last 5 years.  
5.- Young researchers are encouraged to apply and will be prioritized. Senior candidates will be 
considered only if there are not enough qualified junior applicants. 
6.- Repeat awards: The number of times that the same person can receive an HH award is 3 in 
order to each a broader range of researchers. In case of a tie, applicants that have already 
received an H&H award will have lower priority than those not having received any. 
7.- Number of awards per country: No more than 2 awards will go to the same country while 
there are applicants from countries with fewer than that number of applications.  
8.- Number of awards to the same group/institution: Priority will be given to members of 
different groups. No more than 2 awards will go to the members of the same research group 
while there are applicants from other groups. 
9.- Up to two special HH awards could be granted for students from any country with an 
outstanding career and presenting a highly innovative abstract provided that there are not 5 or 
more successful applicants to the regular awards. 
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Application for Helping Hand F lowship to attend 14th International Colloquium on 
Paratuberculosis (14ICP) in Riviera Maya, Mexico, June 4-8 June, 2018 
 
Name:  
Country of origin: 
Date of Birth:  
Educational Qualification:  
Current affiliation: 
      Institution: 
      Country: 
     Group leader: 
Ph.D Thesis Title (if applicable):  
Area of Paratuberculosis Research:  
Publications in Paratuberculosis Research: 
STATEMENT OF PURPOSE  
ABSTRACT (optional) 
 
Applications should be sent by e-mail addressed to the Secretary-Treasurer of the IAP 
(rsweeney@vet.upenn.edu), a d must include the filled in forms provided in the call as an 
attached Word or Adobe pdf file blocked for changes. The IAP Member Support and 
Recognition Committee will evaluate the applications in the name of the IAP and its decisions 
are final. 
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National Johne’s Management Plan in the UK 
Phase II
The National Action Group on Johne’s in the 
UK , a forum for dairy industry organisations 
concerned with tackling Johne’s disease, 
initiated a management plan in 2015 to 
manage and control the disease on farms. 
Phase II of the plan has now commenced. 
 The National Johne’s Management 
Plan (NJMP) was developed to guide the 
management and o reduce the incidence of 
Johne’s disease through implementing one 
of the six strategies. This includes 
approaches such as biosecurity protocols, 
strategic testing and vaccination. Further 
information can be found at 
http://www.actionjohnesuk.org/ As part of 
this initiative there are now over 650 vets 
who are accredited advisors for Johne’s 
disease. 
 
 
Post comments on the IAP website 
 
 
#Paratuberculosis or# Johnes 
  
 If you are a Twitter user which handle do you prefer? Th Journal
of Dairy Science twe ts using both, do you?  
Post comments on the IAP website 
 
Cover photo images 
We are seeking images related to paratuberculosis for the cover of the 
Newsletter. Please submit suitable contributions to 
editor@paratuberculosis.net for consideration. 
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Paratuberculosis News 
The Centre for Agriculture and Biosciences 
International (CABI) is an international not-
for-profit organization that improves lives 
worldwide by providing information and 
applying scientific expertise to solve 
problems in agriculture and the 
environment. They have just updated the 
data sh et for paratuberculosis 
https://www.cabi.org/isc/datasheet/70813 
It has a globa  di ease distribution map 
(shown below) and a more comprehensive 
tabl detailing the presence or absence of 
disease. 
 
 
 
 
Post comments on the IAP website 
 
  
The Paratuberculosis Newsletter  December 2017 
26 
 
Upcoming events 
· The 14th ICP will be held in Cancun, Mexico from J e 4-8 2018
 
 
· The 15th ICP will be held Dublin, Ireland in 2020 
 
 
· The first African Society for Paratuberculosis meeting will be held at the Animal Reproduction 
Research Institute, Giza, Egypt, March 5-7, 2018 
This organization which was formed in February 2017 will serve as a platform for cooperation, to share 
and to knowledge, experiences, materials on Paratuberculosis among African Researchers and 
stakeholders on Paratuberculosis control. 
 
· The 30th World Buiatrics Congress will be held in Sapporo, Japan from 28 
Aug – 1 Sept 2018. The Scientific program will cover issues on cattle health and 
reproduction. Topics will include a wide range of production diseases, major 
infectious diseases, calves and new-born dise ses, tropical epidemiology, public 
health and food security and other animal health and management problems. 
 
· The 6th European Veterinary Immunology Workshop (EVIW) will be held from 5-7 
September 2018 in Utrecht, the Netherlands. Plenary and concurrent session 
topics include: Innate immunity, Adaptive immunity, Infection and immunity, 
Vaccination, Clinical immunology, Allergy, Mucosal immunology and the 
microbiome in relation to immune responses 
 
Are there any other events you a e aware of that could be of interest to other members of the 
IAP? Click here to let us know. 
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